Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients

NCT04869579 is registered in ClinicalTrials.gov with CHRISTUS Health as lead sponsor.

NCT NCT04869579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04869579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients
Lead sponsor
CHRISTUS Health
Phase
Phase 2
Overall status
Unknown status
Start date
August 15, 2021
Completion date
December 15, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19